BRPI0920670A2 - composição nutritiva para promover o desenvolvimento e crescimento sadios - Google Patents

composição nutritiva para promover o desenvolvimento e crescimento sadios

Info

Publication number
BRPI0920670A2
BRPI0920670A2 BRPI0920670A BRPI0920670A BRPI0920670A2 BR PI0920670 A2 BRPI0920670 A2 BR PI0920670A2 BR PI0920670 A BRPI0920670 A BR PI0920670A BR PI0920670 A BRPI0920670 A BR PI0920670A BR PI0920670 A2 BRPI0920670 A2 BR PI0920670A2
Authority
BR
Brazil
Prior art keywords
growth
nutritional composition
healthy development
promote healthy
promote
Prior art date
Application number
BRPI0920670A
Other languages
English (en)
Inventor
Dattatreya Banavara
Deborah A Schade
Donald Carey Walker
Eric Van Tol
Francisco J Rosales
Gyan P Rai
Kristin Morris
Robert J Mcmahon
Zeina E Jouni
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Publication of BRPI0920670A2 publication Critical patent/BRPI0920670A2/pt
Publication of BRPI0920670A8 publication Critical patent/BRPI0920670A8/pt
Publication of BRPI0920670B1 publication Critical patent/BRPI0920670B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Dairy Products (AREA)
BRPI0920670-1A 2008-10-24 2009-10-23 Composição nutritiva para promover o desenvolvimento e crescimento sadios BRPI0920670B1 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US10830308P 2008-10-24 2008-10-24
US61/108,303 2008-10-24
US11100908P 2008-11-04 2008-11-04
US61/111,009 2008-11-04
US12/371,100 2009-02-13
US12/371,100 US8075934B2 (en) 2008-10-24 2009-02-13 Nutritional composition with improved digestibility
US12/464,029 US9386794B2 (en) 2008-10-24 2009-05-11 Nutritional composition to promote healthy development and growth
US12/464,029 2009-05-11
PCT/US2009/061794 WO2010048483A1 (en) 2008-10-24 2009-10-23 Nutritional composition to promote healthy development and growth

Publications (3)

Publication Number Publication Date
BRPI0920670A2 true BRPI0920670A2 (pt) 2015-12-29
BRPI0920670A8 BRPI0920670A8 (pt) 2018-03-20
BRPI0920670B1 BRPI0920670B1 (pt) 2020-10-06

Family

ID=42117714

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0920670-1A BRPI0920670B1 (pt) 2008-10-24 2009-10-23 Composição nutritiva para promover o desenvolvimento e crescimento sadios
BRPI0920402-4A BRPI0920402A2 (pt) 2008-10-24 2009-10-23 Composição nutricional para promover desenvolvimento e crescimento saudável.

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0920402-4A BRPI0920402A2 (pt) 2008-10-24 2009-10-23 Composição nutricional para promover desenvolvimento e crescimento saudável.

Country Status (17)

Country Link
US (3) US8075934B2 (pt)
EP (2) EP2337572B1 (pt)
CN (2) CN102186463B (pt)
BR (2) BRPI0920670B1 (pt)
CA (2) CA2741554C (pt)
CO (2) CO6351713A2 (pt)
CZ (2) CZ2011207A3 (pt)
ES (2) ES2604319T3 (pt)
MX (2) MX2011003179A (pt)
MY (1) MY150595A (pt)
NO (2) NO20110233A1 (pt)
PE (2) PE20110846A1 (pt)
PL (2) PL2337572T3 (pt)
RU (2) RU2501553C2 (pt)
SG (1) SG10201601290VA (pt)
TW (2) TWI483681B (pt)
WO (2) WO2010048483A1 (pt)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010134800A1 (en) * 2009-05-19 2010-11-25 N.V. Nutricia Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution
US20130273207A1 (en) * 2010-09-23 2013-10-17 Pradeep Poddar Calcium Fortifying Composition for Strength, a Hydration Supplement, and Process for Preparing the Same
NZ610471A (en) * 2010-11-02 2014-12-24 Abbott Lab Stable concentrated liquid human milk fortifier
US20120135103A1 (en) * 2010-11-30 2012-05-31 Mead Johnson Nutrition Company Staged Infant Feeding Regimen To Promote Healthy Development And Growth
WO2012091542A1 (en) * 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
DE102011012494A1 (de) * 2011-02-25 2012-08-30 Humana Milchunion Eg Prebiotische Kohlenhydrat-Zusammensetzungen
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
PT3366143T (pt) 2011-06-20 2025-01-07 Heinz Co Brands H J Llc Composições e métodos probióticos
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US9474298B2 (en) * 2011-10-11 2016-10-25 Mead Johnson Nutrition Company Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
MX377791B (es) * 2011-12-30 2025-03-10 Abbott Lab Fortificante líquido concentrado de lecha humana, de baja actividad de agua, que incluye proteína extensamente hidrolizada.
US20130196001A1 (en) * 2012-01-30 2013-08-01 Health & Science, LLC Salt replacement compositions and methods of using same
JP6147009B2 (ja) * 2012-04-02 2017-06-14 日清オイリオグループ株式会社 ゲル状食品
WO2013150468A2 (en) * 2012-04-04 2013-10-10 Nestec S.A. Shelf-stable acidified dairy or dairy-like products and methods for making sam
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
US20140057014A1 (en) * 2012-08-27 2014-02-27 Carol Lynn Berseth Formula Fortifier
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
EP2988617B1 (en) 2013-03-27 2023-08-30 Nutritional Growth Solutions LTD Nutritional supplement for growth enhancement
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP3470074B1 (en) 2013-05-10 2020-10-14 H.J. Heinz Company Brands LLC Probiotics
US9119409B2 (en) * 2013-06-25 2015-09-01 Philip Zorn Water soluble nutritional supplement for ruminants
US9241923B2 (en) * 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10709770B2 (en) * 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US20150119322A1 (en) * 2013-07-31 2015-04-30 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US20160095339A1 (en) * 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
US9993457B2 (en) 2014-11-25 2018-06-12 Abbott Laboratories Method of improving visual processing, visual acuity, or both by administering compositions comprising RRR-alpha-tocopherol and carotenoid to infants
CN104489697A (zh) * 2014-12-19 2015-04-08 成都永安制药有限公司 一种含有低聚甘露糖的具有保健功能的代餐粉及其制备方法
CN113862175A (zh) 2014-12-23 2021-12-31 4D制药研究有限公司 免疫调控
PL3193901T3 (pl) 2014-12-23 2018-10-31 4D Pharma Research Limited Polipeptyd pyrynowy i immunomodulacja
WO2016116580A1 (en) * 2015-01-23 2016-07-28 Nestec S.A. Nutritional composition useful in the treatment of ibd patients
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
MD3206700T2 (ro) 2015-06-15 2019-12-31 4D Pharma Res Ltd Compoziții conținând tulpini bacteriene
RS59446B1 (sr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PE20180267A1 (es) 2015-06-15 2018-02-06 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
WO2017085520A1 (en) 2015-11-20 2017-05-26 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108601813B (zh) * 2016-02-03 2022-02-25 费森尤斯卡比德国有限公司 包含胶原蛋白的高热量高蛋白质营养配方物
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
JP6441536B2 (ja) 2016-03-04 2018-12-19 フォーディー ファーマ ピーエルシー４Ｄ Ｐｈａｒｍａ Ｐｌｃ 細菌株を含む組成物
US9855305B2 (en) 2016-03-29 2018-01-02 Companion Therapeutics Llc Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors
ES2981479T3 (es) * 2016-04-14 2024-10-09 Chromadex Inc Fórmula para lactantes que comprende ribósido de nicotinamida
EP3238676B1 (en) 2016-04-29 2019-01-02 The Procter and Gamble Company Absorbent core with profiled distribution of absorbent material
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US20180332881A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
HUE054164T2 (hu) 2017-05-22 2021-08-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
WO2018215782A1 (en) 2017-05-24 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strain
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
LT3600363T (lt) 2017-06-14 2021-02-10 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
MA49010B1 (fr) 2017-06-14 2020-11-30 4D Pharma Res Ltd Compositions comprenant une souche bactérienne du genre megasphaera et leurs utilisations
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
PH12021552677A1 (en) * 2019-05-15 2022-07-04 Nutricia Nv Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
US12005083B1 (en) 2019-06-24 2024-06-11 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US11849747B1 (en) 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US20220313673A1 (en) * 2019-08-19 2022-10-06 Neuroreserve Inc. Dietary supplements to ameliorate dietary inadequacies related to brain health or neurodegenerative diseases, and methods to design dietary supplements
CN112933104B (zh) * 2021-02-02 2021-12-14 陈玉松 核苷酸的新用途
CN120836753B (zh) * 2025-09-24 2025-12-02 四平君乐宝乳业有限公司 一种用于促进大脑认知发育的组合物及其制备方法和应用

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115645A (ja) 1984-07-03 1986-01-23 Meiji Milk Prod Co Ltd カルシウム強化飲料及びその製造法
US4859488A (en) 1987-09-15 1989-08-22 Kabushiki Kaisha Yakult Honsha Liquid food for curing constipation: polydextrose and oligosaccharide
US4906482A (en) 1986-03-19 1990-03-06 Zemel Michael B Method of making calcium fortified soy milk and the calcium fortified soy milk
GB8723094D0 (en) 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
FI892006A7 (fi) 1988-04-29 1989-10-30 Phil Gold Laktalbumiini ruoan lisäaineena
CA1338682C (en) 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
US5795611A (en) 1989-12-20 1998-08-18 Slattery; Charles W. Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ATE287415T1 (de) 1990-07-13 2005-02-15 Gropep Ltd Wachstumsfördernder wirkstoff
US6319522B1 (en) 1990-07-13 2001-11-20 Gropep Limited Growth-promoting agent
ZA92452B (en) 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
DK0527283T3 (da) * 1991-08-12 1998-08-10 Nestle Sa Levnedsmiddelsammensætning
US5952034A (en) 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
JP2654529B2 (ja) 1992-03-27 1997-09-17 大塚製薬株式会社 健康飲料組成物
US5397589A (en) 1992-09-02 1995-03-14 Ohio State University Research Foundation Preparation of calcium fortified powdered milk products with improved dispersibility
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5605697A (en) 1992-10-27 1997-02-25 Fujisawa Pharmaceutical Co., Ltd. Bifidobacterium growth promotant
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
AUPM534794A0 (en) 1994-04-28 1994-05-19 Gropep Pty Ltd Modified milk growth factor
TW440566B (en) 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
CA2223198A1 (en) 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
EP0852913A1 (en) 1997-01-14 1998-07-15 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
DE19701382A1 (de) 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
JP3186630B2 (ja) 1997-02-14 2001-07-11 株式会社デンソー データ通信方法および車載用通信装置ならびに路上用通信装置
US5840361A (en) 1997-04-09 1998-11-24 Beech-Nut Nutrition Corporation Fructan-containing baby food compositions and methods therefor
PT1003532E (pt) 1997-07-05 2002-04-29 Nestle Sa Lactobacilos para aumentar a absorcao de minerais pelas celulas do intestino
US6841149B1 (en) 1998-05-29 2005-01-11 Agri-King, Inc. Probiotic mixture intended for monogastric animals to control intestinal flora populations
AU4573799A (en) 1998-06-19 2000-01-05 Beth Israel Deaconess Medical Center Dietary supplement for individuals under stress
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6866877B2 (en) 1998-12-29 2005-03-15 Mac Farms, Inc. Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage
EP1034704A1 (en) 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6706287B2 (en) 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
US20040161422A1 (en) 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
WO2001024812A1 (en) 1999-10-06 2001-04-12 N.V. Nutricia USE OF TRANSFORMING GROWTH FACTOR β AND GROWTH FACTORS IN THE TREATMENT AND PREVENTION OF DISEASES OF THE INTESTINAL MUCOSA
CA2387686A1 (en) 1999-10-06 2001-04-12 Campina B.V. Process for obtaining growth factor preparations (tgf-beta and igf-1) from milk products having low mutual cross-contamination
DE19958985A1 (de) 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
EP1062873A1 (en) 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
WO2002089593A1 (en) 2000-02-03 2002-11-14 Kabushiki Kaisha Yakult Honsha Fermented foods and process for producing the same
US6630452B2 (en) 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
BR0108828A (pt) 2000-03-01 2002-12-10 Nestle Sa Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
RU2283665C2 (ru) 2000-12-22 2006-09-20 Сосьете Де Продюи Нестле С.А. Индуцирование толерантности
CA2432884C (en) 2000-12-27 2008-01-22 N.V. Nutricia Nutritional composition with health promoting action containing oligosaccharides
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1228707A1 (en) 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
CA2444470A1 (en) 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US20030000391A1 (en) * 2001-06-12 2003-01-02 Jay Highman Organic nutritional formula
FR2827290B1 (fr) 2001-07-13 2004-07-09 Pierre Jouan Biotechnologies Sa Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
FI20020078A7 (fi) 2002-01-15 2003-07-16 Danisco Immuunijärjestelmän stimulointi polydextroosilla
FI119429B (fi) 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
RU2234933C2 (ru) * 2002-09-19 2004-08-27 Общество с ограниченной ответственностью "ЛЕОВИТ нутрио" Препарат "предиабетин"
CA2500366A1 (en) 2002-10-11 2004-04-22 Wyeth Nutritional formulations containing synbiotic substances
US7138151B2 (en) 2002-11-22 2006-11-21 Unilab Pharmatech, Ltd. Calcium-fortified acidic beverages
US20040191294A1 (en) * 2003-03-27 2004-09-30 Ramaprasad Talahalli Ravichandra Health composition
US20040191295A1 (en) 2003-03-28 2004-09-30 Locniskar Mary Frances Composition and method for viral inhibition
WO2005039318A1 (en) 2003-10-16 2005-05-06 Nestec S.A. Nutritional composition against side effects of chemotherapy of radiotherapy
CN1870910B (zh) 2003-10-24 2010-05-26 努特里奇亚有限公司 婴儿合生素组合物
NZ546785A (en) 2003-10-24 2009-07-31 Nutricia Nv Immunemodulating oligosaccharides
US20050158425A1 (en) 2003-12-04 2005-07-21 Purac Biochem Bv Thin mouthfeel calcium-fortified beverage containing calcium lactate gluconate citrate
GB2412834A (en) * 2004-04-07 2005-10-12 International Ltd Valid A ready-to-use nutritional supplement
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US20060240148A1 (en) 2005-04-13 2006-10-26 The Dannon Company, Inc. High-fiber dairy product
US20060233915A1 (en) * 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060280840A1 (en) * 2005-05-24 2006-12-14 Robertson Marion G Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
KR20080015071A (ko) * 2005-06-06 2008-02-18 브리스톨-마이어스스퀴브컴파니 저-피테이트 유아용 조제유
EP1940248B1 (en) 2005-10-05 2009-12-16 Nestec S.A. Use of a nutritional formulation for promoting catch-up growth
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
US20080095752A1 (en) 2006-10-20 2008-04-24 Win-Chin Chiang Method for extending the shelf-life of powdered nutritional formulations which contain viable probiotics
NL1032840C2 (nl) 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.

Also Published As

Publication number Publication date
TWI487489B (zh) 2015-06-11
US20100104686A1 (en) 2010-04-29
CZ2011206A3 (cs) 2011-09-07
TW201028104A (en) 2010-08-01
EP2337572A4 (en) 2012-08-15
ES2604319T3 (es) 2017-03-06
NO20110233A1 (no) 2011-03-30
CO6351713A2 (es) 2011-12-20
US20100104545A1 (en) 2010-04-29
BRPI0920402A2 (pt) 2020-12-08
MX342733B (es) 2016-10-11
CA2741554A1 (en) 2010-04-29
MY150595A (en) 2014-01-30
RU2011120780A (ru) 2012-11-27
CN102186493A (zh) 2011-09-14
US8287932B2 (en) 2012-10-16
EP2337558B1 (en) 2016-08-31
RU2508121C2 (ru) 2014-02-27
CN102186463A (zh) 2011-09-14
PL2337558T3 (pl) 2017-02-28
CA2741554C (en) 2017-09-05
EP2337558A1 (en) 2011-06-29
WO2010048481A1 (en) 2010-04-29
CN102186493B (zh) 2014-04-09
PE20110846A1 (es) 2011-12-24
EP2337558A4 (en) 2012-08-08
HK1161841A1 (en) 2012-08-10
EP2337572B1 (en) 2016-10-12
MX2011003433A (es) 2011-04-21
PE20110592A1 (es) 2011-09-23
TW201028096A (en) 2010-08-01
CZ2011207A3 (cs) 2011-11-02
CA2740299A1 (en) 2010-04-29
BRPI0920670A8 (pt) 2018-03-20
HK1161840A1 (en) 2012-08-10
EP2337572A1 (en) 2011-06-29
CO6351747A2 (es) 2011-12-20
RU2501553C2 (ru) 2013-12-20
WO2010048483A1 (en) 2010-04-29
CN102186463B (zh) 2013-11-06
US9386794B2 (en) 2016-07-12
US8075934B2 (en) 2011-12-13
CA2740299C (en) 2017-08-22
US20100104696A1 (en) 2010-04-29
SG10201601290VA (en) 2016-03-30
NO340945B1 (no) 2017-07-24
NO20110273A1 (no) 2011-04-28
TWI483681B (zh) 2015-05-11
ES2597527T3 (es) 2017-01-19
BRPI0920670B1 (pt) 2020-10-06
RU2011105430A (ru) 2012-11-27
MX2011003179A (es) 2011-04-21
PL2337572T3 (pl) 2017-03-31

Similar Documents

Publication Publication Date Title
BRPI0920670A8 (pt) composição nutritiva para promover o desenvolvimento e crescimento sadios
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
BRPI0914745A2 (pt) composição nutricional
PL2695528T3 (pl) Kompozycja żywieniowa do usprawniania funkcji mięśni i codziennej aktywności
BRPI1010709A2 (pt) composição nutricional
EP2374452A4 (en) NUTRIENT COMPOSITION
BRPI1014522A2 (pt) composicoes e metodos para aumentar o crescimento muscular
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
BRPI0915481A2 (pt) material e método para produzir o mesmo
BR112012001604A2 (pt) composição para cuidado pessoal
HRP20160737T1 (hr) Anti-her3-protutijela i njihove uporabe
EP3542638C0 (en) Nutritional composition
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BRPI0906501A2 (pt) composição compreendendo proteína e gordura dispersas
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
HRP20170936T1 (hr) Alkilamido spojevi i njihova uporaba
BRPI0818691A2 (pt) Métodos para melhorar o crescimento vegetal.
EP2490542A4 (en) DERMATOLOGICAL AND COSMETIC COMPOSITIONS
EP2298365A4 (en) MEDICAL COMPOSITION AND MEDICAL KIT
BRPI0914023A2 (pt) composição nutricional e método para fornecer uma nutrição
BRPI0821467A2 (pt) Composição, e, métodos pra produzir furina recombinante substancialmente livre de proteína animal, e para utilizar uma composição
BRPI1012696A2 (pt) composicao nutricional compreendendo curminaoides e metodos de fabricacao
BR112012005678A2 (pt) composição para cuidado pessoal
DK2380582T4 (da) Ernæringssammensætning med lav koncentration
BR112012014239A2 (pt) composição para cuidado pessoal

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: MJN U.S. HOLDINGS LLC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/10/2020, OBSERVADAS AS CONDICOES LEGAIS.